Use Of Pigmented Retinal Epithelial Cells For Creation Of An Immune Privilege Site


The present invention relates to a novel in vivo method for creation of a localized immunosuppressive environment in tissue. The method involves the transplanting of pigmented retinal epithelial cells into a mammal thereby producing a localized immunosuppressive environment. The transplanted pigmented retinal epithelial cells may also be used to produce therapeutic proteins or other biologically active molecules that may be useful in treatment of diseases.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 15, 1999
  • Application: Dec 31, 1998
    WO US 9827730 W
  • Priority: Jan 2, 1998
    US US 241398 A

Download Citation

Sign in to the Lens